← Back to headlines
Merck's Oral PCSK9 Enlicitide Demonstrates Superior Cholesterol Lowering
Merck's oral PCSK9 enlicitide has shown improved cholesterol-lowering capabilities when compared to non-statin treatments.
30 Mar, 18:54 — 30 Mar, 18:54
Sources
Showing 1 of 1 sources
Related Stories
Partial Lunar Eclipse Captured by Stargazers Across Multiple Continents
21h ago
Global Observers Watch Partial Lunar Eclipse Covering Most of Moon
23h ago
Partial Lunar Eclipse Draws Global Viewers Despite Cloudy European Skies
1d ago
Rare Partial Lunar Eclipse to Cast Red Glow Across Northern Skies
2d ago